Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and SuicidalityClinicalTrials.gov · 2026-08-12A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic TherapiesClinicalTrials.gov · 2026-08-04An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSDClinicalTrials.gov · 2026-07-29Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of DepressionZenodo (CERN European Organization for Nuclear Research) · 2026-07-17Integrated 5-HT-TrkB and G protein signaling in serotonergic psychedelic responses.Molecular psychiatry · 2026-07-16Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study.medRxiv: the preprint server for health sciences · 2026-07-14Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case ReviewMexican Journal of Medical Research ICSA · 2026-07-05The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review.Journal of psychopharmacology (Oxford, England) · 2026-07-01Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation: Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater · 2026-06-30THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRYInternational Journal of Innovative Technologies in Social Science · 2026-06-14Developing Methods for Observing Awe Narration in Psilocybin-Assisted TherapyHealthcare · 2026-06-05Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic PotentialDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-22265 Self-reported rates of psilocybin use in North Florida, 2012 to presentJournal of clinical and translational science · 2026-05-20Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamineGeneral Hospital Psychiatry · 2026-05-01Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled TrialsOpen Access Indonesian Journal of Medical Reviews · 2026-04-21Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in rat.Acta neuropsychiatrica · 2026-04-10Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic TherapiesClinicalTrials.gov · 2026-03-20Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers.BMJ open · 2026-03-12Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.BJPsych open · 2026-02-16PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSIONInternational Journal of Innovative Technologies in Social Science · 2026-01-28An open-label pilot study of psilocybin-assisted therapy for binge eating disorder.Journal of eating disorders · 2026-01-03Dynamic response of intrinsic connectivity networks to low-dose psilocybin during face matching in autistic adultsNeuroscience Applied · 2026-01-01Additional file 1 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2026-01-01Additional file 2 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2026-01-01Low dose psilocybin differentially alters resting-state network connectivity in autistic and non-autistic peopleNeuroscience Applied · 2026-01-01Effects of low-dose psilocybin on EEG markers of sensory processing in autistic and non-autistic adultsNeuroscience Applied · 2026-01-01Characteristics of Ongoing Clinical Trials for Cocaine Use Disorder Registered on Global Clinical Trial Databases.Journal of addiction medicine · 2026-01-01The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal IdeationClinicalTrials.gov · 2025-12-24Psilocybin Maintains Better Brain Function in an Alzheimer’s Disease Model with Reduced Neuroinflammation and Improved Hippocampal NeurogenesisAlzheimer's & dementia: the journal of the Alzheimer's Association · 2025-12-01Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover TrialPsyArXiv · 2025-11-16Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.Psychopharmacology · 2025-10-01Correction to: Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.Psychopharmacology · 2025-10-01Concomitant use of antidepressants and classic psychedelics: A scoping review.Journal of psychopharmacology (Oxford, England) · 2025-10-01Serotonin 5-HT Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.ACS chemical neuroscience · 2025-10-01Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased AgonismFigshare · 2025-09-13PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCHInternational Journal of Innovative Technologies in Social Science · 2025-09-01Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker.International journal of molecular sciences · 2025-08-07Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.Psychopharmacology · 2025-07-01Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress.Translational psychiatry · 2025-06-14Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.Palliative & supportive care · 2025-04-22Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.Progress in neuro-psychopharmacology & biological psychiatry · 2025-01-10Psilocybin: From Psychiatric Pariah to Perceived Panacea.The American journal of psychiatry · 2025-01-01Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders.Journal of clinical psychopharmacology · 2025-01-01Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushroomsJournal of Psychedelic Studies · 2024-09-09PTSD Treatment: An Inquiry into the Promising Potential of PsilocybinJournal of Advances in Medicine and Medical Research · 2024-07-24The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin.BMC psychiatry · 2024-04-25Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometryAnalytica Chimica Acta · 2024-02-01Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.Neuroscience applied · 2024-01-01Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings.Psychedelic medicine (New Rochelle, N.Y.) · 2023-12-01An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).Pilot and feasibility studies · 2023-10-05Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.JAMA · 2023-09-05Psychedelics for Patients With Cancer: A Comprehensive Literature Review.The Annals of pharmacotherapy · 2023-09-01use of psilocybin in the treatment of psychiatric disorders - reviewJournal of Education Health and Sport · 2023-08-15Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autismmedRxiv · 2023-05-26Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective.International journal of environmental research and public health · 2023-01-19Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal modelNeuroscience Applied · 2023-01-01Biological embedding of early trauma: the role of higher prefrontal synaptic strength.European journal of psychotraumatology · 2023-01-01DNA Authentication and Chemical Analysis of Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites.Applied and environmental microbiology · 2022-12-20THE RENAISSANCE OF PSYCHEDELICS IN PSYCHIATRY: EVIDENCE, ETHICS, AND POTENTIAL IN MENTAL HEALTH TREATMENT FOR ADOLESCENTSJournal of the American Academy of Child & Adolescent Psychiatry · 2022-09-30SP56 Psychedelic drugs and painInvited speakers · 2022-05-31Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine.Expert opinion on investigational drugs · 2022-02-013,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.Frontiers in psychiatry · 2022-01-01Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative reviewResearch Society and Development · 2021-08-19Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials.Drug testing and analysis · 2020-10-01Psilocybin Therapy for Depression: A Scoping Review ProtocolOpen MIND · 2020-01-01Medicinal use of psilocybin: Reducing restrictions on research and treatment.Conservative Drug Policy Reform Group · 2020-01-01Psilocybin and LSD in the Treatment of Depression and AnxietyDiva portal (Dalarna University Library) · 2019-12-31The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress DisorderDiva portal (Dalarna University Library) · 2019-12-31THE POTENTIAL THERAPEUTIC VALUE OF PSILOCYBIN: In Relation to DepressionDiva portal (Dalarna University Library) · 2018-12-311.13 Microdosing of Hallucinogens Among College Students: Frequency, Correlates, and ConsequencesJournal of the American Academy of Child & Adolescent Psychiatry · 2018-09-30High dose psilocybin is associated with positive subjective effects in healthy volunteers.Journal of psychopharmacology (Oxford, England) · 2018-07-01Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.Clinical pharmacokinetics · 2017-12-01Designer Drugs 2.0.Clinical pharmacology and therapeutics · 2017-02-01ChemInform Abstract: PSILOCIN ANALOGS. PART2. SYNTHESIS OF3-(2-(DIALKYLAMINO)ETHYL)-, 3-(2-(N-METHYL-N-ALKYLAMINO)ETHYL)-, AND3-(2-(CYCLOALKYLAMINO)ETHYL)INDOL-4-OLSChemischer Informationsdienst · 1981-08-04Psilocin analogs II. Synthesis of 3-[2-(dialkylamino)ethyl]-, 3-[2-(N-methyl-N-alkylamino)ethyl]-, and 3-[2-(cycloalkylamino)ethyl]indol-4-olsJournal of Heterocyclic Chemistry · 1981-01-01ChemInform Abstract: PSILOCIN ANALOGS. 1. SYNTHESIS OF3-(2-(DIALKYLAMINO)ETHYL)- AND3-(2-(CYCLOALKYLAMINO)ETHYL)INDOL-4-OLSChemischer Informationsdienst · 1977-07-12GLC-Mass Spectral Analysis of Psilocin and PsilocybinJournal of Pharmaceutical Sciences · 1977-05-01Psilocin analogs. 1. Synthesis of 3-[2-(dialkylamino)ethyl] -and 3-[2-(cycloalkylamino)ethyl] indol-4-olsJournal of Heterocyclic Chemistry · 1977-02-01Baeocystin in Psilocybe semilanceata.Journal of pharmaceutical sciences · 1977-01-01The effects of psilocybin on primary process content in language.Confinia psychiatrica. Borderland of psychiatry. Grenzgebiete der Psychiatrie. Les Confins de la psychiatrie · 1977-01-01